Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Review Article
ARTICLE IN PRESS
doi:
10.25259/IJDVL_1117_2023

Role of cosmetic camouflage in improving quality of life in dermatological disorders: A narrative review

Department of Dermatology, Government Medical College and Hospital, Chandigarh, India

Corresponding author: Prof. Mala Bhalla, Department of Dermatology, Government Medical College and Hospital, Chandigarh, India. malabhalla@yahoo.co.in

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Arora A, Bhalla M. Role of cosmetic camouflage in improving quality of life in dermatological disorders: A narrative review. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_1117_2023

Abstract

Camouflage is a system of techniques using cosmetics to conceal, diminish and disguise visible disfigurements of pigment or texture of skin mainly over visible areas. A wide variety of options are available which can be used as camouflage cosmetics. Over the years many authors have published studies highlighting the importance of camouflage in different dermatological disorders like pigmentary, vascular, scars, acne vulgaris and many more. In this review we present 15 such studies assessing QOL in patients of dermatological diseases who were given camouflage therapy. The evidence presented here gives us an insight into the positive effects of camouflage/cover up make up when offered to patients with different dermatological conditions.

Keywords

Cosmetic camouflage
quality of life
dermatological disorders.

Introduction

Skin, hair and nails are crucial organs of cosmetic importance and they form the medium of expression of one’s individuality. Flawless skin in today’s social media–driven lifestyle has become a goal for one and all. Even slight imperfections seem unacceptable and are a cause of concern for patients suffering from pigmentary disorders, vascular lesions or in fact any blemish on the visible parts of the body. The pursuit of flawlessness has become of utmost importance. The treatments for such disorders usually take time to show results, therefore the use of corrective make up to cover the lesions till they show a clinical response has been shown to improve the patient’s quality of life.

Camouflage, when simply described, is a system of techniques using cosmetics to conceal, diminish and disguise visible disfigurements of pigment or texture of skin mainly over visible areas. The main purpose is to help cope with the psychological effects by helping to normalise appearance and increase social acceptability. It was first introduced during World War II to help burn victims improve their appearance and then further integrated with medical management by Joyce Allsworth, who formed the British Association of Skin Camouflage.1-4

A wide variety of options are available which can be used as camouflage cosmetics. The features common to all are that they should be opaque, waterproof, provide a good colour match, easy to apply and have good adherence to skin allowing long wear. The formulations of the camouflage cosmetics include creams, creamy and alcohol-based liquids, sticks and roll-ons. They usually have higher pigment content and fillers, thereby making them more opaque and more efficacious than commonly used make up. Various companies provide commercially available camouflage cosmetics in multiple colours, common ones being Dermacolor, Microskin and Dermablend Cover Creme Foundation. Theories of colour correction following the colour wheel and contouring to match skin’s imperfections also need to be considered for providing a good camouflage of lesions.5,6

In order to help patients learn the subtleties of application of camouflage make up, the British Red Cross Society provides education services to patients in the United Kingdom free of cost in the Skin Camouflage clinic. These services are supplemented by Changing Faces which is a charity organisation providing trained practitioners of camouflage and teaching and providing patients with medical makeup free of charge. In the United States, state-licensed medically trained camouflage therapists are available, who not only have the knowledge to demonstrate but also educate patients on how to use make up correctly.1,7.8

Despite evidence of the ability of camouflage to improve the quality of life (QOL) in patients of facial disfigurement, dermatologists still do not practice it regularly for their patients. A cross-sectional study published by Sandhu et al. demonstrated that dermatology residents, although aware about camouflage, did not recommend it regularly and were not convinced of its role in clinical dermatology practice. The study highlighted the need to include camouflage awareness and training during residency to increase acceptability among dermatologists.9

In today’s social media–driven world, the impact of various dermatological diseases on the QOL is being increasingly recognized and studied. To keep up with changing patient needs, a shift towards supportive care is the need of the hour whereby dermatologists institute camouflage or corrective make up to patients with dermatological disorders along with treatments to improve their QOL. To support this change, we present this review of studies assessing QOL in patients of dermatological diseases who were given camouflage therapy.

Material and Methods

A literature search of PubMed electronic database was performed using key words ‘camouflage’and ‘dermatology’. A total of 22 search results appeared. Studies including case reports, clinical study, clinical trial, Phase IV, controlled clinical trial, multicentre study, and randomised controlled trial focusing on dermatological disorders have been included in this review. The studies that assessed QOL improvement by any of the multiple available tools were included. Only five relevant studies were found and abstracts of these were studied and reviewed by the two authors. The relevant references of the included articles were also traced and included, making a total of 15 case series and clinical trials. Studies focusing on QOL improvement in burn scars, post-radiation scarring, surgical scars, and head and neck cancers were not included in this review [Figure 1].

Flow chart depicting the process of data collection and study analysis.
Figure 1:
Flow chart depicting the process of data collection and study analysis.

The objective of the review was to collate and analyse the evidence to suggest the impact of camouflage techniques on QOL improvement in various dermatological disorders using the available QOL indices.

Results

Study Selection and Overview

After literature research and cross-referencing, 15 studies10-24 were included, of which 9 studies included multiple indications. Only four studies focused on vitiligo, one on acne vulgaris and one on lupus erythematosus.13,14,16,22-24 Although all 15 were prospective studies, the control group was only present in 4 studies.14,16,22,23 The age groups included were varied in most studies with four studies focusing on the paediatric age group15,19-21 [Table 1].

Table 1: Descriptive analysis of the studies which have been reviewed
No. of Studies
Total 15
Indications Studied Vitiligo 413,16,23,24
Acne 114
Systemic lupus erythematosus 122
Multiple 9
Type of Study Prospective studies 15
Control group present 414,16,22,23
Duration of Studies Minimum 2 weeks
Maximum 24 weeks
Mean 7.6 weeks
Age Group Studied Adults 9
Paediatrics 415,19,20,21
Both 2
QOL Questionnaire Used DLQI 10
cDLQI 415,19,20,21
Other QOL questionnaires

Skindex 1612

QOL perception without skin blemish12

WHOQOL 2614

fDLQI21

EuroQOL5D24

SF3624

Disease specific

SLE QOL22

VitiQOL24

Psychological effect

FNE12

Worry over skin disease12

Rosenberg self-esteem questionnaire22

Hospital Anxiety and Depression Scale22

DLQI: Dermatology Life Quality Index; FNE: fear of negative evaluation; QOL: Quality of life; cDLQI: Children’s Dermatology Life Quality Index; fDLQI: Family Dermatology Life Quality Index; SLEQoL: Systemic Lupus Erythematosus – Specific Quality Of Life; HADS: Hospital Anxiety and Depression Scale: EQ5D: EuroQol-5 Dimension questionnaire; SF36: Short Form Health Survey; ViTiQol: Vitiligo Quality-Of-Life Index.

Patient Demographics

A total of 893 patients were recruited and data have been analysed for 775 patients. The demographic details of the patients, different diagnostic categories studied, and number of patients in these individual classes has been described in Table 2. Mean duration of disease was provided only in eight studies with minimum duration being 1.625 years and maximum being 18.8 years with a mean of 10.6 years.

Table 2: Patient demographic data and dermatological indications
Total patients recruited 893
Patients analysed 775
Age (in years) Mean (mean of mean) 33.4
Range 4–79
Male : Female Ratio 1:5.63
Dermatological indications   No. of patients
Pigmentary Vitiligo 266 (34.3%)
Melasma 22 (2.8%)
Lentigo, Café au lait macules, post-inflammatory hyperpigmentation 9 (1.1%)
Not defined 71 (9.1%)
Acne and Scars 127 (16.3%)
Vascular 67 (8.6%)
Rosacea 30 (3.8%)
Connective Tissue Disease Lupus erythematosus 46 (5.9%)
Morphea 4 (0.5%)
Not Defined 4 (0.5%)
Scarring 47 (6%)
Nevus 12 (1.5%)
Others/Undefined 70 (9%)

The details of the included studies have been included in Table 3.

Table 3: Detailed descriptions of the studies reviewed
S No. Study, Year Type

No of Patients

(Analysed)

Age Sex Indication Duration Outcome Measure Result
1 Boehncke et al., 200210 Prospective study 20 16-69

M – 0

F – 20

Acne, Rosacea, CLE, Vitiligo 2 weeks DLQI

Improved from 9.2 at baseline to 5.5.

More improvement in less severe scores.

2 SA Holme et al., 200211 Prospective study 82 16-78

M – 6

F – 76

Pigmentary

Scar

Vascular

Rosacea

Others

1 month DLQI Improved from 9.1 to 5.8.
3 Bal Krishnan et al., 200512 Prospective study 63 19-46

M – 0

F – 63

Acne

Pigmentary

Vascular

Rosacea

naevi

3 months

Skindex-16 scores, FNE scores, QOL perception

with and without facial blemish and worry

about skin discoloration

Skindex-16 – 59.8 to 40.2

FNE – 37.6 to 33.6

QOL perception

with and without facial blemish – 4.2 to 1.4

Worry

about skin discolouration – 8.8 to 4.7

4 Ongenae, 200513 Open label study 62 16-68

M – 6

F – 56

Vitiligo 1 month

DLQI,

Adapted stigmatisation questionnaire

Significant improvement in DLQI – 7.3 to 5.9

Adapted stigmatisation questionnaire – 38.4% reduction

Stigmatisation questionnaire
5 Matsuoka et al., 200614 Randomised control

50

A (25) – demonstration of use of cosmetics with treatment

B(25) – only treatment

A - 24±3

B – 25±5

M – 0

F - 50

Acne 4 weeks WHO QOL26 DLQI

WHO QOL26

A – 3.27 to 3.39

B – 3.36 to 3.44

DLQI

A – 8.24 to 3.88

B – 6.24 to 3.24

6 Tedeschi et al., 200715 Prospective study 15 7–16

M – 3

F – 12

Acne

Vitiligo

Becker’s Nevus

Striae distensae

Allergic contact dermatitis

Post-surgery scarring

2 weeks Satisfaction of parents in providing cover
7 Tanioka et al., 201016 Prospective control study

32

A – (21) – given camouflage lessons

B – (11) – no lessons given

A – 48.1

B – 40.8

M –

A – 11

B – 6

F

A – 10

B – 5

Vitiligo 4 weeks DLQI

DLQI improvement in both groups

A – 5.9 to 4.48

B – 3.18 to 4.36

Maximum improvement in item 2

8

Seite et al.,

201217

Prospective study 129 42±1.4

M – 7

F – 122

Acne

Vascular

Pigmentary

Others

4 weeks DLQI

Improved from 9.9 to 3.49

More improvement in item 9 with improvement in all other items.

S No. Study, Year Type

No of Patients

(Analysed)

Age Sex Indication Duration Outcome Measure Result
9 Peuvrel et al., 201218 Open prospective study 63 4–79

M – 7

F – 79

(of the 86 recruited)

Acne

Rosacea

Scars

Vascular

Pigmentary

Connective tissue diseases

1 month DLQI

Significant improvement in DLQI – 7.3 to 4.6

More improvement in acne, rosacea and scar

Items 1 and 2 showed maximum improvement.

Questionnaire of ease of application.
10 Padilla-Espana et al., 201319 Case Report 6 10-15

M – 1

F – 5

Acne

Nevus

Vitiligo

2 weeks cDLQI Improvement in cDLQI – 10.6 to 4.33
11 Ramien,201420 Open label prospective study 38 5-18

M – 4

F – 37 (41 initially recruited)

Vascular

Nevus

Vitiligo

Post-inflammatory hyperpigmentation

6 months cDLQI

Improved from 5.1 to 2.1

More improvement in pigmentary and vascular abnormalities.

12 Salsberg et al., 201521 Open label prospective study 22 5-17

M – 3

F – 19

Vascular

Nevus

Vitiligo

Morphea

Café au lait macules

1 month

cDLQI

fDLQI

Significant improvement

cDLQI – 6.82 to 3.05

fDLQI – 7.68 to 4.68

13 Oliveiria et al., 202022 Randomised controlled intervention study

43

A (28)– Intervention – use camouflage

B (15)- control

38-55

M – 0

F – 43

Systemic lupus erythematosus

(Discoid, subacute cutaneous and acute lesions)

24 weeks

SLEQoL

DLQI Rosenberg self-esteem scale

HADS

SLEQoL –

A –118 to 96.5

B – 89 to 153

DLQI

A – 8.5 to 3.5

B – 8.0 to 7.0

Rosenberg self-esteem scale

A – 27 to 29.5

B – 27 to 29.0

Hospital Depression Scale

A – 8.0 to 7.0

B – 5.0 to 5.0

Hospital Anxiety Scale

A – 9.0 – 8.0

B – 6.0 – 9.0

14 Bassioumy et al., 202023 Prospective randomised study

100

A (40) – camouflage group

B (60) – control group

4-70

M -56

F – 44

Vitiligo 4 weeks DLQI

Improved

A – 13.4 to 7.5

B – 11.9 to 10.6

Camouflage usage questionnaire
15 Morales et al., 202224 Uncontrolled quasi experimental study 45 42.4 ± 13.7

M – 10

F – 35

Vitiligo 16 weeks

VitiQol

DLQI

EQ5D

SF36

VitiQol – 46.2 to 31.9

DLQI – 8.0 to 3.0

EQ5D– 82 to 90

SF36 –

Emotional limitations 100 to 100

Emotional well-being 68 to 76

Social functioning 75 to 100

DLQI: Dermatology Life Quality Index; FNE: fear of negative evaluation; QOL indicates quality of life; WHOQOL26: World Health Organization (WHO)QOL26; cDLQI: Children’s Dermatology Life Quality Index; fDLQI: Family Dermatology Life Quality Index; SLEQoL: Systemic Lupus Erythematosus – Specific Quality Of Life Scale; HADS: Hospital Anxiety and Depression Scale; EQ5D: EuroQol-5 Dimension questionnaire; SF36: Short Form Health Survey; ViTiQol: Vitiligo Quality-Of-Life Index.

Quality of Life Measures Analysed

Dermatology Life Quality Index (DLQI) was the most commonly used QOL index used in 10 of the 15 studies individually or in combination with other scoring systems. Similarly, Children DLQI (cDLQI) was a standard QOL used in studies on the paediatric population.25,26 The mean pre-treatment DLQI was 8.68 which reduced to 4.37 after camouflage therapy with maximum pre-treatment value being as high as 13.4 and minimum post-treatment value falling to 3.0. Similarly, a reduction in cDLQI was also observed with mean pre-treatment value of 7.5 and post-treatment value of 3.16.

DLQI comparison between diagnostic categories

Four studies discussed the QOL improvement in different diagnostic categories, mainly pigmentary, acne, vascular and scarring. Holme et al. observed maximum improvement in DLQI in scarring category (10.2–5.6) followed by vascular (8–3.3) and pigmentary (8.6–6.3) with p values <0.0001, <0.01 and <0.05, respectively.11 Seite et al. also reported a similar result with larger improvement of DLQI among patients with vascular disorders (5.35–3.26, P, 0.0001) but contrastingly smaller improvement among individuals with scars (5.52–4.39, P, 0.0001).17 Peuvrel et al. stated significant change in DLQI in two of the three disorder sub-groups, i.e., acne (p = 0.006) and rosacea (p = 0.036), and scar group also showed a decreasing trend (p = 0.057).18 Ramien et al. showed improvement in cDLQI in both main categories, namely, vascular and pigmentary. In vascular category, cDLQI reduced from 4.1 to 1.0 (p 0.003) and pigmentary anomalies from 6.2 to 3.2 (p – 0.020). Patients with vascular malformations showed maximum reduction from 5.5 to 1.5 (p - 0.002) under the vascular category.20

Individual parameter changes in DLQI

DLQI is a 10-item questionnaire analysing QOL under different spheres like symptoms and feelings, daily activities, leisure, work and school, personal relationship, and discomfort of treatment. Seven studies discussed the most affected items and further the items that showed most improvement and these have been described in Table 4. The most affected area was symptoms and feelings followed by daily activities and these parameters showed significant improvement in addition to leisure. But in the study by Holme et al. which was one of the earliest studies, the highest score was in the area of symptoms and feelings and daily activities and leisure. A reduction was observed in all scores post-camouflage use but interestingly personal relationship showed the most improvement with approximately 80% reduction in scores as compared to other parameters.11

Table 4: Individual DLQI item analysis
Study Indication Item Affected Item Most Improved
Holme et al.11 Multiple Symptoms and feelings, daily activities and leisure (2,4,5) Personal relationships (8,9)
Ongenae et al.13 Vitiligo Symptoms and feelings and daily activities (2,4) Symptoms and feelings, daily activities and leisure (1,2,4,6)
Matsouka et al.14 Acne Symptoms and feelings and daily activities (1,2,3,4) Symptoms and feelings, daily activities, leisure and personal relationships (1,2,5,6,8,9)
Tanioka et al.16 Vitiligo All Symptoms and feelings (1,2)
Seite et al.17 Multiple Symptoms and feelings (2) Symptoms and feelings, daily activities and leisure (2,3,5)
Peuvrel et al.18 Multiple Data not available Symptoms and feelings, daily activities (1,2,3,4)
Ramien et al.20 Multiple Data not available Symptoms and feelings, daily activities and leisure (1,2,3,4,5)

Other Scores

Balkrishnan et al. discussed QOL improvement in various disorders using Skindex 16 which reduced from 59.8 to 40.2, fear of negative evaluation which reduced from 37.6 to 33.6, worry about skin discoloration which reduced from 8.8 to 1.4, and QOL perception with and without skin blemish which reduced from 4.2 to 1.4.12

Ongenae et al. in addition to DLQI used a stigmatisation questionnaire in which anticipation of rejection (56%, SD 21%) and guilt and shame (58%, SD 20%) are the most affected ones.13

Matsouka et al. used World Health Organization (WHO) QOL26 (WHOQOL 26) and DLQI in a comparative study on female acne patients. WHOQOL 26 was affected in all domains, and in the intervention group, maximum improvement was observed in the psychological domain.14

Olivieria et al. performed a comparative analysis in patients of systemic lupus erythematosus and used a disease-specific score Systemic Lupus Erythematosus – Specific Quality Of Life Scale (SLEQoL) which showed a significant reduction in the camouflage group (Friedman’s test p ¼ 0.005) with improvement in areas of mood and self-image and physical functioning. Psychological and self-esteem impact was assessed using the Rosenberg self-esteem scale score and anxiety and depression using the Hospital Anxiety and Depression Scale. Although there were no statistically significant changes in the scores at follow-up, improvement in self-esteem (p - 0.041), anxiety (p - 0.045), and depression (p - 0.033) was still observed as an independent observation.22 Morales et al. studied 45 patients of vitiligo and used vitiligo-specific Vitiligo Quality-Of-Life Index which showed significant reduction from 46.2 ± 22.7 to 31.9 ± 20.4 and p <0.001. Another scoring system used was EuroQol-5 Dimension questionnaire, a visual analogue scale–based system and it showed improvement from 82 to 90 (p - 0.007). Short Form Health Survey analysed emotional limitations, emotional well-being, and social functioning which all showed improvement.24

Discussion

QOL of an individual is a major determinant of mental and social health, with ill health usually resulting in it’s deterioration. Dermatological disorders, especially chronic disfiguring dermatoses, are major contributors resulting in a decline of QOL and this has been well substantiated in literature. Over the years, physicians have tried to devise various techniques to help improve the QOL of their patients over and above therapeutic treatment. Camouflage forms an important subset of these techniques which, when used appropriately under the right guidance, proves to be an important tool in patients suffering from visible deformities of skin and associated structures.27-29

This review included studies focused on quantifying improvement in QOL of various dermatological disorders after camouflage therapy using various parameters of assessment [Table 1]. It was observed that camouflage can be used for multiple indications which can broadly be classified as pigmentary disorders, acne, vascular abnormalities, and scarring.

Pigmentary diseases including vitiligo, melasma, lentigo, café au lait macules, and post-inflammatory hyperpigmentation were the most commonly evaluated indications, of which vitiligo was the most common. It was observed that DLQI assessment in these patients showed significant improvement in scores after camouflage use. Vitiligo was the most commonly studied pigmentary disorder, likely because it causes significant deformity in skin of colour as the colour discrepancy is more evident. These disorders prove to be an ideal dermatosis for camouflage therapy as the skin texture is maintained and only the skin colour needs to be corrected by a carefully matched skin shade. The improvement in QOL in these individuals was lesser when compared to other indications but this may be because of the stigma associated with it. This issue should be explored in larger studies.30-32 Some authors believe that camouflage therapy may hamper the treatment of vitiligo but Li et al. in 2020 found that there was no difference in repigmentation and transepidermal water loss in patients using dihydroxyacetone containing camouflage as compared to controls.33

Acne was another indication evaluated in the paediatric and the young adult population. Severe acne, mainly affecting the young adults, is an important cause of psychological stress leading to depression, anxiety and suicidal tendencies. Improvement in QOL with reduction in DLQI scores was observed in patients advised camouflage therapy in addition to medical treatment of acne.34,35 Cosmetics usually are considered to exacerbate acne and rarely advised by dermatologists. But Hayashi et al. in 18 female patients observed that make up designed for acne-prone skin did not worsen the severity of acne; rather, it significantly improved the QOL.36

Vascular lesions include a large variety like spider angiomas, port wine stain, haemangiomas, telangiectasia, etc., and the treatment options are often limited and have questionable efficacy. As observed, vascular lesions showed maximum improvement in QOL when compared to other indications. This may be due to the fact that these lesions especially on visible areas cause significant cosmetic disfigurement due to colour contrast. Camouflage using colour correction and correct skin matching may give an apparently normal appearance to the patients thereby improving QOL in lesions that may otherwise have minimal curative options.37-40

Camouflage by using colour correction and concealing may give an apparently normal appearance to the patients and thereby improve QOL in lesions that may otherwise have minimal curative options. Scarring due to acne, post-surgery, post-trauma or radiation causes change in both colour and texture of skin causing a visible deformity with scarce options of correction. Scars, although symbolising survival and being inevitable, may be a source of anxiety and stress to patients. Thus, scars when corrected with camouflage using contour correction help improve QOL. Camouflage used in patients immediately post-surgery to cover scars has been shown to improve QOL and provide better recovery psychologically.41-44

In the studies in this review, a vast array of scoring systems were utilised, the most common being DLQI which is a widely used and validated QOL measure designed for dermatology patients. As reviewed, camouflage therapy showed improvement in symptoms and feelings questions of the questionnaire signifying that it decreases the feelings of embarrassment and self-consciousness in the patients about their appearance due to the skin disease.25,26 Other scoring systems also showed similar patterns of improvement in areas of appearance, self-esteem and psychological well-being. These scores helped to objectively evaluate the efficacy of camouflage in improving QOL and validate its utility in regular clinical dermatological practice.

Conclusion

The evidence presented here gives us an insight into the positive effects of camouflage/cover up make up when offered to patients with different dermatological conditions. It leads us to reflect and re-analyse the supportive clinical care of patients with visible disfigurements beyond standard treatment protocols and encourages us to explore the field of camouflage therapy to provide better QOL to our patients.

Declaration of patient consent

Patient’s consent not required as there are no patients in this study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. . Camouflage therapy. Dermatol Clin. 1995;13:467-72.
    [PubMed] [Google Scholar]
  2. . Make-up as an adjunct and aid to the practice of dermatology. Dermatol Clin. 1991;9:81-8.
    [PubMed] [Google Scholar]
  3. . Skin camouflage-A guides to remedial techniques: Cover creams. Stanley Thornes publishers; . p. :18-33.
  4. . n.d. Available from: https://skin-camouflage.net/scwp/index.php/history-of-skin-camouflage/?cn-reloaded=1. [Last accessed on 2023 October 15]
  5. . Camouflage and make-up preparations. Dermatol Clin. 2001;19:406-12.
    [Google Scholar]
  6. . Colored facial cosmetics. Dermatol Clin. 2000;18:621-31.
    [CrossRef] [PubMed] [Google Scholar]
  7. . The contribution of skin camouflage volunteers in the management of vitiligo. Case Reports. 2011;2011:bcr0920114783.
    [CrossRef] [PubMed] [Google Scholar]
  8. . Changing faces. Available from: https://www.changingfaces.org.uk/services-support/skin-camouflage-service/. [Last accessed on 2023 October 15]
  9. , , . Knowledge, attitude, and practice of cosmetic camouflage among dermatology residents. Pigment Int. 2021;8:166-72.
    [Google Scholar]
  10. , , , , . Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol. 2002;12:577-80.
    [PubMed] [Google Scholar]
  11. , , . Cosmetic camouflage advice improves quality of life. Br J Dermatol. 2002;147:946-9.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. Corrective cosmetics are effective for women with facial pigmentary disorders. Cutis. 2005;75:181-7.
    [PubMed] [Google Scholar]
  13. , , , , . Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210:279-85.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , . Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. J Dermatol. 2006;33:745-52.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , . Corrective camouflage in pediatric dermatology. Cutis. 2007;79:110-2.
    [PubMed] [Google Scholar]
  16. , , , . Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010;9:72-5.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Interest of corrective makeup in the management of patients in dermatology. Clin Cosmet Investig Dermatol. 2012;5:123-8.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses. Dermatology. 2012;224:374-80.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , . Camouflage therapy workshop for pediatric dermatology patients:A review of six cases. Actas Dermosifiliogr. 2014;105:510-4.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. J Am Acad Dermatol. 2014;71:935-40.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , . Impact of cosmetic camouflage on the quality of life of children with skin disease and their families. J Cutan Med Surg. 2016;20:211-5.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , , . Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study. Lupus. 2020;29:1438-48.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , , et al. Cosmetic camouflage as an adjuvant to vitiligo therapies: Effect on quality of life. J Cosmet Dermatol. 2020;00:1-7.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , . Effect of cosmetic camouflage in adults with vitiligo. Actas Dermosifiliogr. 2022;113:316-8.
    [CrossRef] [PubMed] [Google Scholar]
  25. , . Dermatology life quality index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Clinical experience and psychometric properties of the children’s dermatology life quality index (CDLQI), 1995–2012. Br J Dermatol. 2013;169:734-59.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Quality of life assessment among patients suffering from different dermatological diseases. Saudi Med J. 2021;42:1195-200.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  28. , . The stigma of skin disease. Curr Opin Pediatr. 2019;31:509-14.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , . Alterations in mental health and quality of life in patients with skin disorders: A narrative review. Int J Dermatol. 2022;61:783-91.
    [CrossRef] [PubMed] [Google Scholar]
  30. , . Quality of life in patients with vitiligo: An analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55:608-14.
    [CrossRef] [PubMed] [Google Scholar]
  31. . Cosmetic camouflage in vitiligo. Indian J Dermatol. 2010;55:211-4.
    [CrossRef] [PubMed] [Google Scholar]
  32. , . Camouflage for patients with vitiligo. Indian J Dermatol Venereol Leprol. 2012;78:8-16.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , . Evaluation of the potential interference of camouflage on the treatment of vitiligo: An observer-blinded self-controlled study. Dermatologic Therapy 2020:e14545.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , . Skin disease in children: Effects on quality of life, stigmatization, bullying, and suicide risk in pediatric acne, atopic dermatitis, and psoriasis patients. Children (Basel). 2021;8:1057.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  35. , , . Metabolic status, obesity, and quality of life in patients with acne vulgaris: A cross-sectional case-control study. Indian J Dermatol. 2021;66:223.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , , . Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol. 2005;15:284-7.
    [PubMed] [Google Scholar]
  37. , , . Patient’s evaluation of argon laser therapy of port wine stain, decorative tattoo, and essential telangiectasia. Lasers Surg Med. 1984;4:181-90.
    [CrossRef] [PubMed] [Google Scholar]
  38. , . Psychological disabilities amongst patients with port wine stains. Br J Dermatol. 1989;121:209-15.
    [CrossRef] [PubMed] [Google Scholar]
  39. . The stigma of port wine stains. Br J Hosp Med. 1991;45:274-6.
    [PubMed] [Google Scholar]
  40. . Cutaneous vascular lesions. Facial Plast Surg Clin North Am. 2013;21:111-26.
    [CrossRef] [PubMed] [Google Scholar]
  41. , . The art of corrective makeup: How to camouflage unattractive scars and blemishes. New York, NY: Doubleday; .
  42. , . Medical makeup for concealing facial scars. Facial Plast Surg. 2012;28:536-40.
    [CrossRef] [PubMed] [Google Scholar]
  43. , , , , . Recommendations for the use of corrective makeup after dermatological procedures. J Cosmet Dermatol. 2022;21:1554-8.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  44. , . Camouflage therapy in aesthetic surgery. Clin Dermatol. 2014;32:813-6.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections